ISB News

2013 ISB Symposium: Systems Biology & the Brain

ISB's annual Symposium draws top scientists from across the country as speakers.

ISB’s annual Symposium draws top scientists from across the country as speakers.

What will the next decade hold for brain science? At ISB’s 12th Annual International Symposium: Systems Biology and the Brain, which took place on April 14-15, we began exploring this question.

With the announcement in January about the European Commission awarding $1.29 billion to The Human Brain Project (based in Switzerland) and the news in February that the Obama administration would be announcing a $3 billion plan to support the BRAIN Initiative, brain research is a hot topic.

The Symposium is ISB’s marquee scientific event and each year it draws top-level speakers who collectively help advance systems biology. This year, U.S. Rep. Jim McDermott delivered the welcome and shared his thoughts on the importance of continued federal support for basic science research.

U.S. Rep. Jim McDermott gave the welcome address at the 2013 ISB Symposium.

U.S. Rep. Jim McDermott gave the welcome address at the 2013 ISB Symposium.

The opening keynote talk was presented by Dr. Christof Koch, the chief scientific officer at the Allen Institute for Brain Science. ISB collaborates with the Allen Institute on research, so we were particularly thrilled that Dr. Koch could join us.

Christof Koch is the chief scientific officer at the Allen Institute for Brain Science.

Christof Koch is the chief scientific officer at the Allen Institute for Brain Science.

There were about 200 attendees, including one 13-year-old advanced student who has an interest in science.

Related Content:

Recent Articles

  • Drs. Naeha Subramanian, Leah Rommereim Gilmore, and Ajay Suresh Akhade

    Small, Persistent Increase in the Expression of NOD1 May Promote Cancer Risk

    ISB researchers have found that a small, persistent increase in the expression of NOD1 could be responsible for higher cancer risks. The research team found that a slight 1.5-fold uptick in NOD1 expression can activate the protein and downstream signaling pathways in a manner similar to vast (30- to 200-fold) overexpression.

  • CRI iAtlas

    CRI iAtlas Expands to Interactive Analysis of Data on Immunotherapy Treatments

    CRI iAtlas is a comprehensive web-based resource that allows oncologists and researchers to study and analyze interactions between tumors and the immune microenvironment. The iAtlas team released immuno-oncology modules that allow investigators to access and work with genomics data from trials of treatment with immune-checkpoint inhibitors.

  • Last-Minute Gift Ideas: 2020 Edition

    Wait, what day is it? What month is it? This year has been a doozy. The pandemic has fundamentally changed our lives, and at times, has made us feel like we’re in a real-life Groundhog Day. Well, if you’ve found yourself in the last-minute shopping scramble, we’re back with a half dozen solid ideas that we hope will make your gift-giving life easier.